(Nanowerk Spotlight) Nucleic acids are becoming increasingly popular for assembling nanoscale structures, thanks to their programmable dimensionality and direct applications in the biological field.

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...